About Genom Biotech Private Limited
Data last updated:
Genom Biotech Private Limited is a private limited company based in Sinnar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2000PTC123931. Its GSTIN is 27AABCG1013B1ZI (Maharashtra).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.85 Cr. It is led by directors including Raunit Rathor and Managobinda Dalai.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at D: 121 122 123 M.I.D.C. Malegaon Sinnar Nasik, Maharashtra, India – 422103.
As per the financials filed for FY 2020, the company reported a revenue of ₹4.2 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net loss of ₹3.62 Cr (net margin -86.1%) and EBITDA of -₹1.85 Cr (EBITDA margin -43.9%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years.
The company has about 123 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹34.38 Cr and satisfied charges of ₹7.7 Cr on record. Court records list 65 cases involving the company, including 12 filed by the company and 53 filed against it; 16 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomworld.com.
Company details
Contact details
Genom Biotech Private Limited's registered office is in Sinnar, Maharashtra. Its website is genomworld.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressD: 121 122 123 M.I.D.C. Malegaon Sinnar Nasik, Maharashtra, India – 422103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Genom Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Genom Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Genom Biotech Private Limited, buy the company report.
Financials of Genom Biotech Private Limited
FY 2020 filings availableGenom Biotech Private Limited reported revenue of ₹4.2 Cr (up 27% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over three years, including 27% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹4.2 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -43.9% | ||||
| Net Profit Margin | -86.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genom Biotech Private Limited, buy the company report.
Board of directors of Genom Biotech Private Limited
Genom Biotech has 3 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raunit Rathor Also directs: Clestra Life Sciences Private Limited | Director | 27 Oct 2018 | 8 Years 0 Months | Current |
| Managobinda Dalai Also directs: Clestra Life Sciences Private Limited | Director | 10 May 2021 | 5 Years 6 Months | Current |
| Singh Binod Kumar Sheila | Director | 01 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Genom Biotech Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarva Pharmaceuticals Private Limited | ₹4.22 Cr (FY 2024) | -39.0% | Delhi, India | |||
| Sharun Pharmaceuticals Private Limited | ₹4.21 Cr (FY 2024) | -16.0% | Puducherry, India | |||
| Genom Biotech Private Limitedthis company | ₹4.2 Cr (FY 2020) | -₹3.62 Cr | -86.1% | 27.0% | 123 | Sinnar, Maharashtra, India |
| BDH Healthcare Private Limited | ₹4.19 Cr (FY 2025) | -79.0% | Mumbai, Maharashtra, India | |||
| Hexadox Pharmaceuticals Private Limited | ₹4.18 Cr (FY 2025) | 23.0% | Bangalore, Karnataka, India | |||
| Liva Pharmaceuticals Limited | ₹4.15 Cr (FY 2019) | 24.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Genom Biotech Private Limited, buy the company report.
Auditor
Genom Biotech Private Limited is audited by H L SHAH & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H L SHAH & ASSOCIATES | FY 2020 | 004057C |
Shareholding
The shareholding of Genom Biotech Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Genom Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2005 | 90237689 | Vijaya Bank | ₹3 Cr | Open | |
| 09 Mar 2005 | 90237686 | Vijaya Bank | ₹25 Lakh | Open | |
| 01 Jan 2005 | 90237665 | B.K.C. | ₹25 Lakh | Open | |
| 31 May 2004 | 90237622 | Hdfc Bank Ltd. | ₹3.5 Cr | Open | |
| 03 Apr 2004 | 90232856 | Bank of India | ₹13.51 Cr | Open |
To see the full charge records of Genom Biotech Private Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Genom Biotech Private Limited has 65 court cases on record: 12 filed by Genom Biotech, 53 filed against it. 16 cases are pending and 49 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 36 | 29 | 1 |
| High courts | 29 | 24 | 15 |
Cases on record (5 of 65)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by M/S. SRC Express Cargo Pvt. Ltd. | Disposed |
| Bombay High Court | Company petition | Filed against the company by M/S Simons Shipping Pvt. Ltd. | Disposed |
| Bombay High Court | Company petition | Filed against the company by M/S. Rukson Packaging Pvt. Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrent Cases SW) | Filed against the company by Zeus Air Services Pvt Ltd | Disposed |
| High Court, MAHARASHTRA | Tax appeal | Filed against the company by PR. Commissioner of Income Tax-6, Suresh Kumar | Pending |
To see the full case history of Genom Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genom Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Genom Biotech Private Limited has a workforce of 123 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 123 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 | |
| FY 2014-15 | |
| FY 2013-14 | |
| FY 2007-08 | |
| FY 2006-07 |
To see the full employee and EPFO history of Genom Biotech Private Limited, buy the company report.
GST
Genom Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCG1013B1ZI | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Genom Biotech Private Limited, buy the company report.
Recent activity
Genom Biotech Private Limited has 21 board changes on record since 2008: 3 appointments and 18 cessations. The latest: Managobinda Dalai ceased to be Additional Director on 30 Nov 2021.
28 earlier events are in the company report.
Frequently asked questions
Genom Biotech is an active private limited company based in Sinnar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 January 2000 (26+ years old) and is registered under CIN U24239MH2000PTC123931.
Genom Biotech has 3 current directors:
- Raunit Rathor - Director
- Managobinda Dalai - Director
- Singh Binod Kumar Sheila - Director
The latest financial statements of Genom Biotech on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Genom Biotech is 27AABCG1013B1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Genom Biotech is U24239MH2000PTC123931. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genom Biotech has 65 court cases on record: 12 filed by the company and 53 filed against it. 16 are pending. Most are in the district courts.
Genom Biotech was incorporated on 31 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Genom Biotech by revenue are Sarva Pharmaceuticals Private Limited, Sharun Pharmaceuticals Private Limited, BDH Healthcare Private Limited, Hexadox Pharmaceuticals Private Limited, Liva Pharmaceuticals Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Managobinda Dalai ceased to be Additional Director on 30 Nov 2021. Raunit Rathor ceased to be Additional Director on 30 Nov 2021. Singh Binod Kumar Sheila ceased to be Additional Director on 30 Nov 2021. Genom Biotech has 21 board changes on record in total.
Genom Biotech can be reached through the website genomworld.com. Its registered office is in Sinnar, Maharashtra, India.
The registered office of Genom Biotech is at D: 121 122 123 M.I.D.C. Malegaon Sinnar Nasik, Maharashtra, India – 422103.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
